ZACKS INVESTMENT MANAGEMENT

Position in PAHC — Phibro Animal Health Corp

CIK 1086483 Chicago, IL

Position in PAHC

as of Jun 30, 2026 · filed Aug 13, 2026 Compact

Position Value

$3,210,116

-$2,127,740 QoQ

Shares Held

102,233

+5.9% QoQ

Ownership

0.252%

of shares outstanding

% of Portfolio

0.02%

of 13F equity value

Holder Rank

#38

of 206 holders

Holding Since

Sep 2024

8 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

ZACKS INVESTMENT MANAGEMENT holds $9,127,553 across 4 Drug Manufacturers - Specialty & Generic names. PAHC ranks #2 (35.2% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	NBIX	Neurocrine Biosciences Inc	20,271	$3,416,474
2	PAHC	Phibro Animal Health Corp This page	102,233	$3,210,116
3	COLL	Collegium Pharmaceutical, Inc	52,672	$1,906,726
4	INDV	Indivior Pharmaceuticals, Inc.	14,483	$594,237

8 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$3,210,116	102,233	+5.9%	Shares	Sole	2026-08-13
2026-03-31	$5,337,856	96,508	+5.6%	Shares	Sole	2026-05-14
2025-12-31	$3,414,367	91,391	+13.2%	Shares	Sole	2026-02-17
2025-09-30	$3,267,103	80,749	+13.1%	Shares	Sole	2025-11-14
2025-06-30	$1,823,249	71,388	+14.8%	Shares	Sole	2025-08-12
2025-03-31	$1,328,506	62,196	+19.1%	Shares	Sole	2025-05-14
2024-12-31	$1,096,662	52,222	+329.5%	Shares	Sole	2025-02-13
2024-09-30	$273,798	12,158	—	Shares	Sole	2024-11-14
No filing history on record for this holder in this stock.